Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 24 studies | 44% ± 18% |
Insufficient scRNA-seq data for expression of FOXP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 92% | 64.18 | 531 / 578 | 96% | 5.89 | 1104 / 1155 |
skin | 89% | 98.74 | 1601 / 1809 | 90% | 5.46 | 426 / 472 |
breast | 82% | 40.57 | 378 / 459 | 95% | 6.38 | 1065 / 1118 |
prostate | 90% | 51.08 | 220 / 245 | 88% | 2.26 | 440 / 502 |
thymus | 89% | 50.81 | 584 / 653 | 75% | 3.26 | 455 / 605 |
liver | 91% | 125.25 | 206 / 226 | 66% | 3.93 | 267 / 406 |
ovary | 71% | 22.66 | 128 / 180 | 83% | 3.15 | 359 / 430 |
intestine | 61% | 69.56 | 585 / 966 | 90% | 4.55 | 476 / 527 |
esophagus | 52% | 45.73 | 747 / 1445 | 97% | 5.91 | 177 / 183 |
bladder | 62% | 23.24 | 13 / 21 | 86% | 4.21 | 434 / 504 |
stomach | 56% | 18.07 | 201 / 359 | 92% | 5.51 | 263 / 286 |
uterus | 55% | 13.50 | 94 / 170 | 91% | 4.81 | 419 / 459 |
brain | 97% | 57.59 | 2551 / 2642 | 37% | 0.63 | 264 / 705 |
kidney | 78% | 38.43 | 69 / 89 | 54% | 1.83 | 487 / 901 |
pancreas | 19% | 3.77 | 62 / 328 | 85% | 4.25 | 152 / 178 |
spleen | 100% | 204.05 | 240 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.71 | 44 / 45 |
peripheral blood | 97% | 169.09 | 901 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 19.82 | 28 / 29 |
adrenal gland | 71% | 20.22 | 184 / 258 | 17% | 0.36 | 40 / 230 |
adipose | 55% | 16.54 | 657 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 37% | 11.43 | 490 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 33% | 0.81 | 26 / 80 |
heart | 11% | 2.28 | 91 / 861 | 0% | 0 | 0 / 0 |
muscle | 5% | 1.02 | 37 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006954 | Biological process | inflammatory response |
GO_0014045 | Biological process | establishment of endothelial blood-brain barrier |
GO_0035739 | Biological process | CD4-positive, alpha-beta T cell proliferation |
GO_0050777 | Biological process | negative regulation of immune response |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0032693 | Biological process | negative regulation of interleukin-10 production |
GO_0032792 | Biological process | negative regulation of CREB transcription factor activity |
GO_0045066 | Biological process | regulatory T cell differentiation |
GO_0033092 | Biological process | positive regulation of immature T cell proliferation in thymus |
GO_0050687 | Biological process | negative regulation of defense response to virus |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0002456 | Biological process | T cell mediated immunity |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0033080 | Biological process | immature T cell proliferation in thymus |
GO_0042110 | Biological process | T cell activation |
GO_0043029 | Biological process | T cell homeostasis |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0032914 | Biological process | positive regulation of transforming growth factor beta1 production |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0032831 | Biological process | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO_0048289 | Biological process | isotype switching to IgE isotypes |
GO_0002677 | Biological process | negative regulation of chronic inflammatory response |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0002870 | Biological process | T cell anergy |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0032700 | Biological process | negative regulation of interleukin-17 production |
GO_0048294 | Biological process | negative regulation of isotype switching to IgE isotypes |
GO_1901355 | Biological process | response to rapamycin |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0032905 | Biological process | transforming growth factor beta1 production |
GO_0001782 | Biological process | B cell homeostasis |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0002513 | Biological process | tolerance induction to self antigen |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0032714 | Biological process | negative regulation of interleukin-5 production |
GO_0002669 | Biological process | positive regulation of T cell anergy |
GO_0048302 | Biological process | regulation of isotype switching to IgG isotypes |
GO_0002667 | Biological process | regulation of T cell anergy |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_2000562 | Biological process | negative regulation of CD4-positive, alpha-beta T cell proliferation |
GO_0002262 | Biological process | myeloid cell homeostasis |
GO_0002725 | Biological process | negative regulation of T cell cytokine production |
GO_0009615 | Biological process | response to virus |
GO_0002851 | Biological process | positive regulation of peripheral T cell tolerance induction |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_2000320 | Biological process | negative regulation of T-helper 17 cell differentiation |
GO_0046007 | Biological process | negative regulation of activated T cell proliferation |
GO_0032713 | Biological process | negative regulation of interleukin-4 production |
GO_0002362 | Biological process | CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment |
GO_0045591 | Biological process | positive regulation of regulatory T cell differentiation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005829 | Cellular component | cytosol |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0051525 | Molecular function | NFAT protein binding |
GO_0035035 | Molecular function | histone acetyltransferase binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0051059 | Molecular function | NF-kappaB binding |
Gene name | FOXP3 |
Protein name | FOXP3 protein (Forkhead box P3) Forkhead box P3 Forkhead box protein P3 (Scurfin) [Cleaved into: Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form] |
Synonyms | JM2 IPEX |
Description | FUNCTION: Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg) . Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells . Can act either as a transcriptional repressor or a transcriptional activator depending on its interactions with other transcription factors, histone acetylases and deacetylases . The suppressive activity of Treg involves the coordinate activation of many genes, including CTLA4 and TNFRSF18 by FOXP3 along with repression of genes encoding cytokines such as interleukin-2 (IL2) and interferon-gamma (IFNG) . Inhibits cytokine production and T-cell effector function by repressing the activity of two key transcription factors, RELA and NFATC2 . Mediates transcriptional repression of IL2 via its association with histone acetylase KAT5 and histone deacetylase HDAC7 . Can activate the expression of TNFRSF18, IL2RA and CTLA4 and repress the expression of IL2 and IFNG via its association with transcription factor RUNX1 . Inhibits the differentiation of IL17 producing helper T-cells (Th17) by antagonizing RORC function, leading to down-regulation of IL17 expression, favoring Treg development . Inhibits the transcriptional activator activity of RORA . Can repress the expression of IL2 and IFNG via its association with transcription factor IKZF4 (By similarity). . |
Accessions | B7ZLG1 ENST00000455775.7 ENST00000376199.7 [Q9BZS1-2] A0A804HK12 A0A494BZV0 Q9BZS1 ENST00000557224.6 [Q9BZS1-3] ENST00000684155.1 ENST00000376207.10 [Q9BZS1-1] ENST00000652559.1 A0A494C0B0 ENST00000651307.1 ENST00000518685.6 [Q9BZS1-4] |